pentobarbital will decrease the level or influence of meloxicam by influencing hepatic enzyme CYP2C9/ten metabolism. Minor/Importance Unknown.
pentobarbital will lower the level or result of atorvastatin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will reduce the level or influence of elbasvir/grazoprevir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic influence of elbasvir/grazoprevir may very well be reduced if coadministered with potent CYP3A inducers and is particularly thus contraindicated.
pentobarbital will minimize the extent or result of alosetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unfamiliar.
pentobarbital will reduce the extent or outcome of tolterodine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will decrease the extent or influence of vincristine liposomal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Mysterious.
pentobarbital will decrease the extent or effect of solifenacin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will lower the extent or outcome of tacrolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
fentanyl transdermal and pentobarbital both of those boost sedation. Stay clear of or Use Alternate Drug. Limit use to sufferers for whom alternative treatment method possibilities are insufficient
pentobarbital will decrease the extent or outcome of cevimeline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Mysterious.
pentobarbital will reduce the level or impact of lorlatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the extent or influence of pitolisant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. Pitolisant publicity is lowered by fifty% if coadministered with solid CYP3A4 inducers.
pentobarbital will lower the level or result of ziprasidone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Nembutal Unidentified.
pentobarbital will lessen the extent or impact of capivasertib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Sturdy or moderate CYP3A inducers decrease capivasertib publicity, which can reduce efficacy.